Back
ESC Premium Access

Beta-blocker treatment in atrial fibrillation with chronic obstructive pulmonary disease: a Danish nationwide study from 1995 to 2015

Session: Atrial fibrillation: risks and management
Topic: Epidemiology, Prognosis, Outcome
Speaker: Mr C. Benson (Copenhagen, DK)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

Like

About the speaker

Mr Christan Suppli Benson

Herlev and Gentofte Hospital, Copenhagen (Denmark)
0 follower

4 more presentations in this session

Risk of dementia according to smoking cessation after newly diagnosed atrial fibrillation: a nationwide cohort study

Speaker: Doctor H. Lee (Seoul, KR)

Access
Abstract
Slides
Video
Like
Thumbnail

Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study

Speaker: Doctor S. Lee (Seoul, KR)

Access
Abstract
Slides
Video
Like
Thumbnail

Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts - the BiomarCaRE project.

Speaker: Professor D. Rothenbacher (Ulm, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study

Speaker: Mr P. Nielsen (Aalborg, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Atrial fibrillation: risks and management

Speakers: Mr C. Benson, Doctor H. Lee, Doctor S. Lee, Professor D. Rothenbacher, Mr P. Nielsen
Access
Like
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources